Vertex Pharmaceuticals has given Mirum Pharmaceuticals the blueprint for success in rare diseases.

Inside the deadly disease confounding medicine, researchers piecing together clues and the breakthrough that meant survival ...

A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...

Underwriters were given a 30-day option to purchase up to 1.74 million additional shares. ・Trevi is currently developing Haduvio, its treatment for chronic cough in patients with idiopathic pulmonary ...

Cautionary Language Concerning Forward-Looking Statements ...

University of Colorado Denver Biomedical Engineering Associate Professor Chelsea Magin is developing a lung model to help ...

After a few months away from the spotlight, the royal who suffers from lung disease pulmonary fibrosis made a public ...

The initial public offering (IPO) market showed signs of life for the first time in more than a month as Boston-based Avalyn ...

Crown Princess Mette-Marit of Norway wore a nasal cannula to a royal duty for the first time on April 10. Inside the latest ...

In a bar, a poet meets the man behind the drug that saved his life — discovering how science, faith and chance created a ...

Backed by Novo Holdings and multiple other prominent investors, the biotech is developing what it’s positioning as superior ...

The Willard community is putting its support behind the city’s police chief, Tom McClain, as he underwent surgery for a ...